Main Street Capital earnings on deck as investors eye NAV growth

Eli Lilly (LLY +0.76%) was second to market with a GLP-1 weight-loss drug, losing out to Novo Nordisk (NVO 2.31%). However, Eli Lilly’s Mounjaro and Zepbound produce stronger weight-loss results than Novo Nordisk’s Wegovy, and they quickly took the lead. Now, many on Wall Street see Eli Lilly as a GLP-1 stock, which it is….

Alaska, Norway, and Chile recognized the economic and political risks that accompany commodity booms and established sovereign wealth funds to preserve their resource revenues. Argentina’s hydrocarbon- and lithium-rich provinces should learn from their experience. BUENOS AIRES—Argentinian President Javier Milei has launched a reform program inspired by the free-market economist Friedrich Hayek, at the heart of…

Trump says he will add to Canadian tariffs due to wildfire smoke as two Minnesota fires cross into Canada !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}

Partial support provided in 2025 by grant number 90PH0032 from the Office of Planning, Research & Evaluation within the Administration for Children and Families (ACF), a division of the U.S. Department of Health and Human Services (HHS), totaling $7.84 million with 99% funded by ACF/HHS and 1% funded by nongovernment sources. The opinions, findings, conclusions,…

In many ways, Space Exploration Technologies (SPCX +9.43%) — aka SpaceX — has confounded investors since its record-breaking debut. The company raised $85.7 billion in its initial public offering (IPO) and ended the day with a record market cap of $2.1 trillion. Since then, however, volatility has been the default. After soaring as much as…